"Tarzana Treatment Centers, Inc. is dedicated to providing professional health care that treats each person with compassion and according to their assessed individual needs for improved physical and mental wellbeing. We provide whole-person healthcare through our integrated programs of primary medical and behavioral healthcare including inpatient medical detoxification and psychiatric stabilization, residential and outpatient substance use disorder treatment, outpatient mental health, and residential rehab for teens / youth and adults, primary care clinics, and HIV/AIDS services including specialty medical care."

During the past decade, Tarzana Treatment Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tarzana Treatment Center" #1 sponsor was "NYU Langone Health" with 2 trials, followed by "University of California, Los Angeles" with 2 trials sponsored, "Alkermes, Inc." with 1 trials sponsored, "New York University" with 1 trials sponsored and "Oregon Health and Science University" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tarzana Treatment Center" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Jackson Health System" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "Oregon Research Institute" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Tarzana Treatment Center" are "Opioid-use Disorder" (3 trials), "HIV Infections" (2 trials), "Opioid Use Disorder" (2 trials), "Cocaine Dependence" (1 trials) and "Hiv" (1 trials). Many other conditions were trialed in "Tarzana Treatment Center" in a lesser frequency.

Most popular intervention types in "Tarzana Treatment Center" are "Drug" (5 trials), "Behavioral" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Behavior Therapy" (1 trials), "Brief Strategic Family Therapy (BSFT)" (1 trials), "Buprenorphine-Naloxone" (1 trials), "CBD 1200 mg" (1 trials) and "Cannabidiol (CBD) 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tarzana Treatment Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Tarzana Treatment Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Tarzana Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tarzana Treatment Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".